| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/14/2005 | CN1668750A Her-2/neu DNA vaccine having anti-cancer activity |
| 09/14/2005 | CN1668737A Recombined Bet-V-1 allergen mutants, its preparation method and equipment |
| 09/14/2005 | CN1668734A Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure |
| 09/14/2005 | CN1668721A Immunoadhesin comprising a glycoprotein VI domain |
| 09/14/2005 | CN1668645A Methods and copositions for the treatment of ischemic reperfusion |
| 09/14/2005 | CN1668642A Method for isolating an intestinal cholesterol binding protein |
| 09/14/2005 | CN1668630A Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/14/2005 | CN1668629A Modulation of the expression of genes dependent on STAT-1 |
| 09/14/2005 | CN1668575A Tgents and methods for the treatment of disorders associated with oxidative stress |
| 09/14/2005 | CN1668337A Agents for gene therapeutic for cerebrovascular disorders |
| 09/14/2005 | CN1668333A Stable pharmaceutical composition comprising erythropoietin |
| 09/14/2005 | CN1668332A Liquid formulations with a high concentration of human growth hormone (HGH) comprising glycine |
| 09/14/2005 | CN1668330A Peptide derivative fusion inhibitors of HIV infection |
| 09/14/2005 | CN1668327A Transdermal botulinum toxin compositions |
| 09/14/2005 | CN1668326A Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 09/14/2005 | CN1668325A Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 09/14/2005 | CN1668323A Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 09/14/2005 | CN1668322A Cardioprotective therapies based on enzymatic elimination of lipid peroxides by allene oxide synthase |
| 09/14/2005 | CN1668312A Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions |
| 09/14/2005 | CN1668311A Method and composition for treating diabetes |
| 09/14/2005 | CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 09/14/2005 | CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 09/14/2005 | CN1668293A Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 09/14/2005 | CN1668290A Modified amino acid for the inhibition of platelet aggregation |
| 09/14/2005 | CN1668212A Compositions comprising lactoferrin |
| 09/14/2005 | CN1667416A Diagnostics and therapeutics for glaucoma |
| 09/14/2005 | CN1666997A Fusion protein, gene encoding same, and use thereof |
| 09/14/2005 | CN1666778A Anti-oxidation, anti-senium oyster product and its preparation method |
| 09/14/2005 | CN1666777A Medicinal preparation of brain protolysate for injection and preparation method thereof |
| 09/14/2005 | CN1219062C Mouse cholesterol ester synthetase-2 gene promotor |
| 09/14/2005 | CN1219057C Cell factor CKLF-HIA with functions of hematopoietic stimulation and immunoregulation and its variant CKLF-HIB |
| 09/14/2005 | CN1218961C Osteoclast formation inhibitive factor, its nucleotide sequence and preparation method |
| 09/14/2005 | CN1218958C Novel cyclosporin with improved activity profile |
| 09/14/2005 | CN1218943C 4-pyrimidine-N-acyl-L-phenylalanines compound |
| 09/14/2005 | CN1218747C Medicinal use of agkistrodon acutus thrombase for treating hemorrhagic disease |
| 09/14/2005 | CN1218746C Method for preparing medicine targeted liposome |
| 09/14/2005 | CN1218696C Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 09/13/2005 | US6943246 3′terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof |
| 09/13/2005 | US6943245 Gene for which is located on the short arm of human chromosome 1; gene is directly implicated in colon, kidney and breast cancers |
| 09/13/2005 | US6943244 Human g-type lysozyme, the encoding sequence, preparing method and the uses thereof |
| 09/13/2005 | US6943239 Antigenic fusionprotein carrying Galα1,3Gal epitopes |
| 09/13/2005 | US6943236 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 09/13/2005 | US6943235 p24P4C12 polypeptide which(a) consists of the amino acid sequence MGGKQRDEDDEAYG, encoded by cDNA contained in plasmid p24P4C12-GTE5 or p24P4Cl2-GTE9 |
| 09/13/2005 | US6943233 Cyclic peptides and aids vaccines |
| 09/13/2005 | US6943211 polymer strands formed from at least one ethylenically unsaturated monomer(when titrated with a base form negatively charged groups) and linking the polymer strands by at least one linking group containing a hydrolytically susceptible bond |
| 09/13/2005 | US6943180 Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors |
| 09/13/2005 | US6943170 N-cycloalkylglycines as HIV protease inhibitors |
| 09/13/2005 | US6943153 administering genetic engineered adeno-associated virus as angiogenesis inhibitors for prophylaxis of vision defects |
| 09/13/2005 | US6943151 Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds |
| 09/13/2005 | US6943150 Antiapoptosis polypeptides or fusion proteins coded by nucleic acids |
| 09/13/2005 | US6943149 Thrombosis, restenosis, hypertension, heart failure, arrhy-thmia, inflammation, angina, stroke, atherosclerosis, cancer, ischemic conditions, angiogenesis related disorders, neuro-degenerative disorders |
| 09/13/2005 | US6943148 Methods for delivering therapeutics across blood-barrier and for altering receptor binding affinity |
| 09/13/2005 | US6943147 Cancer treatment using proANP peptides |
| 09/13/2005 | US6943146 Control cell proliferation, cell differentiation; culture product |
| 09/13/2005 | US6943145 Compounds and method for the prevention and treatment of diabetic retinopathy |
| 09/13/2005 | US6943026 A mixture of first and second nucleic acid constructs, is used for gene therapy, as antitumor agents, antiproliferative agents, suppressed by a wild-type p53 allele in non-tumour cells relative to tumor cells, prodrug activating thymidine kinase |
| 09/13/2005 | US6943022 Inhibition of apoptosis by the expression of antisense RNA of caspase-3 |
| 09/13/2005 | US6943018 Transgenic expression from a SOCS-3 promoter in vertebrate cells |
| 09/13/2005 | US6943013 DNA expression vector; host cell transformed, transfected or infected with the vector; transgenic cell, tissue or organism; HCDS1 protein |
| 09/13/2005 | US6943000 Detection of modulator of enzyme activity; obtain cells, incubate with modulator, monitor adjustment in enzyme activity, adjustment in activity indicates modulator |
| 09/13/2005 | US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 09/13/2005 | US6942986 Detecting inducer in sample; obtain sample, incubate with bacterial extract, measure light generated by bacteria, |
| 09/13/2005 | US6942985 Diagnosisng colon or rectal cancer in mammals; obtain tissue sample, detect concentration of preferential receptor protein, amplified concentration of protein indicates cancer |
| 09/13/2005 | US6942984 Used to treat apoptotic disorder like cancer, autoimmune disorder, viral infections, Alzheimer's disease, Parkinson's disease or aplastic anemia; treats inflammatory disorders like arthritis, Crohn's disease, psoriasis, allergy or asthma |
| 09/13/2005 | US6942983 An isolated monoclonal antibody is used for binding and detecting a polypeptide having amino acid sequence with valine at residue 835, modulate kinase activity in cells, protein kinase C |
| 09/13/2005 | US6942982 FEBP1 protein vector host cells and method for making FEBP1 protein |
| 09/13/2005 | US6942981 Method of determining interactions with PDZ-domain polypeptides |
| 09/13/2005 | US6942979 Method for screening substances capable of modulating the activity of a TRAAK potassium channel |
| 09/13/2005 | US6942978 Diagnosing cancer by detecting a TADG-12 protein in biological sample, immunoaffinity to an antibody, bioassay, immunoassay |
| 09/13/2005 | US6942967 Drug screening an apoenzyme inhibitor, for use as antidiabetic agent, antilipemic agent, hypoglycemic agent; incubating a synthetic RNA sequence, adding reverse transcriptase and a radiolabelled nucleotide, detecting the absence of deamination |
| 09/13/2005 | US6942963 measuring cytoxicity; drug screening |
| 09/13/2005 | US6942870 For prevention of photodamage skin, for topical application |
| 09/13/2005 | US6942862 Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins |
| 09/13/2005 | US6942861 Functional bacterial protein, intimin, and its use as an antigen for protecting against infection by or transmission of bacteria expressing intimin-like proteins, such as certain pathogenic strains of Escherichial coli |
| 09/13/2005 | US6942858 Compositions containing bacteriophages and methods of using bacteriophages to treat infections |
| 09/13/2005 | US6942856 Glycoprotein matrix compositions and methods related thereto |
| 09/13/2005 | US6942855 recombinant vaccinia virus having a deletion of the region encoding the C-terminal seven amino acids of the E3L gene product and comprising exogenous DNA; use in genetic vaccines for example |
| 09/13/2005 | US6942854 Orally-administered interferon-tau compositions and methods |
| 09/13/2005 | US6942853 Latent fusion protein |
| 09/13/2005 | US6942852 N-terminal modifications of RANTES and methods of use |
| 09/13/2005 | CA2426703C Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 09/13/2005 | CA2335394C Aerothricin analogs, their preparation and use |
| 09/13/2005 | CA2322805C Fat emulsions for inhalational administration |
| 09/13/2005 | CA2175476C Opioid receptor: compositions and methods |
| 09/12/2005 | CA2458084A1 Novel process for octreotide synthesis |
| 09/09/2005 | WO2005083441A2 Diagnostic and therapeutics for diseases associated with proto-oncogene tyrosine-protein kinase (fyn) |
| 09/09/2005 | WO2005083124A1 Antisense oligonucleotide modulation of stat3 expression |
| 09/09/2005 | WO2005083098A1 Recombinant perforin, expression and uses thereof |
| 09/09/2005 | WO2005083085A1 Treatment of hyperproliferative disease |
| 09/09/2005 | WO2005083075A1 Novel gene participating in epidermal differentiation and use thereof |
| 09/09/2005 | WO2005083072A1 Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli |
| 09/09/2005 | WO2005083070A1 Pharmaceutical composition for lowering blood sugar level |
| 09/09/2005 | WO2005083068A2 Methods for obtaining thermostable enzymes, dna polymerase i variants from thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications to the same |
| 09/09/2005 | WO2005083067A1 New protein mitogen-activated protein kinase map3kx and uses thereof |
| 09/09/2005 | WO2005082941A1 Bone sialoprotein collagen-binding peptides |
| 09/09/2005 | WO2005082935A1 Stamp modulation of glucocorticoid-responsive gene expression |
| 09/09/2005 | WO2005082930A2 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof |
| 09/09/2005 | WO2005082927A2 Antihypertensive peptides |
| 09/09/2005 | WO2005082894A1 Cell targeting conjugates |
| 09/09/2005 | WO2005082422A1 Combination of ad-p53 and chemotherapy for the treatment of tumours |